Are attention deficit hyperactivity disorder and chronic fatigue syndrome allergy related? What is fibromyalgia?

Allergy and Asthma Proceedings

Volumn 26, Issue 1, 2005, Pages 19-28

  Bellanti, Joseph A ^a   Sabra, Aderbal ^a   Castro, Henry J ^a   Chavez, Jaime R ^a   Malka Rais, Jonathan ^a   Mendez De Inocencio, Julia ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; BENZOIC ACID; DOPAMINE; FOOD ADDITIVE; METHYLPHENIDATE; NEUROTRANSMITTER; TARTRAZINE;

ALLERGY; ATTENTION DEFICIT DISORDER; CHRONIC FATIGUE SYNDROME; CLINICAL FEATURE; CLINICAL TRIAL; DIET THERAPY; DOPAMINE METABOLISM; EPIDEMIOLOGICAL DATA; FIBROMYALGIA; FOOD COMPOSITION; HISTORY OF MEDICINE; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; LABORATORY TEST; NEUROBIOLOGY; NEUROCHEMISTRY; NEUROENDOCRINE SYSTEM; PATHOGENESIS; PATHOPHYSIOLOGY; PHYSICAL EXAMINATION; REVIEW; SYMPTOMATOLOGY; THEORETICAL STUDY; VIRUS INFECTION;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; FATIGUE SYNDROME, CHRONIC; FIBROMYALGIA; HUMANS; HYPERSENSITIVITY; INFECTION; NEUROSECRETORY SYSTEMS; STRESS;

EID: 17144399908     PISSN: 10885412     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. Sampson HA. Food allergy. J Allergy Clin Immunol 111:540-547, 2003.
2. Warner JO, Bateman BJ, and Stevenson JE. Behavior and adverse food reactions. In Food Allergy: Adverse Reactions to Foods and Food Additives. Metcalfe DD, Sampson HA, and Simon RA (Eds). Malden: Blackwell Publishing, 522-531, 2003.
3. Bock SA, Sampson HA, Atkins FM, et al. Double-blind, placebo-controlled food challenge (DBPCFC) as an office procedure: A manual. J Allergy Clin Immunol 82:986-997, 1988.
4. Nsouli TM, Nsouli SM, and Bellanti JA. Part I. Neuroimmunoallergic inflammation: New pathogenetic concepts and future perspectives of immediate and late allergic reactions. Ann Allergy 60:379-389, 1988.
5. Nsouli TM, Nsouli SM, and Bellanti JA. Part II. Neuroimmunoallergic inflammation: New pathogenetic concepts and future perspectives of immediate and late allergic reactions. Ann Allergy 60:483-492, 1988.
6. Still GF. Some abnormal psychical conditions in children. Lancet 1:1008-1012, 1077-10; 82:1163-68, 1902.
7. Still GF. Some abnormal psychical conditions in children. Lancet 1:1008-1012, 1077-10; 82:1163-68, 1902.
8. Barkley RA (Ed). Attention Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment. New York: The Guilford Press, 1998.
9. Dickerson JW, and Pepler F. Diet and hyperactivity. J Hum Nutr 34:167-174, 1980.
10. Brown RT, Freeman WS, Perrin JM, et al. Prevalence and assessment of attention-deficit/hyperactivity disorder in primary care settings. Pediatrics 107:E43, 2001.
11. Epstein MH, Cullinan D, and Polloway EA. Patterns of maladjustment among mentally retarded children and youth. Am J Ment Defic 91:127-134, 1986.
12. Faraone SV, Biederman J, Mick E, et al. A family study of psychiatric comorbidity in girls and boys with attention-deficit/hyperactivity disorder. Biol Psychiatry 50:586-592, 2001.
13. Sabra A, Bellanti JA, Malka-Rais J, et al. IgE and non-IgE food allergy. Ann Allergy Asthma Immunol 90:71-76, 2003.
14. Hourihane JO, and Rolles CJ. Morbidity from excessive intake of high energy fluids: The "squash drinking syndrome." Arch Dis Child 72:141-143, 1995.
15. Feingold BF. Hyperkinesis and learning disabilities linked to artificial food flavors and colors. Am J Nurs 75:797-803, 1975.
16. Swain AR, Dutton SP, and Truswell AS. Salicylates in foods. J Am Diet Assoc 85:950-960, 1985.
17. National Advisory Committee on Hyperkinesis and Food Additives. Final report to the Nutrition Foundation, New York, 1980.
18. Conners CK, Goyette CH, Southwick DA, et al. Food additives and hyperkinesis - Controlled double blind experiment. Pediatrics 58:154-166, 1976.
19. Goyette CH, Conners CK, Patti TA, et al. Effects of artificial colors on hyperactive children: A double blind challenge study. Psychopharmacol Bull 14:39-40, 1978.
20. Conners CK, Goyette CH, and Newman EB. Doze-time effect of artificial colors in hyperactive children. J Learn Diff 13:512-516, 1980.
21. Conners CK. Artificial colors in the diet and disruptive behavior: Current status of research. In Nutrition and Behaviour. Miller SA (Ed). Philadelphia: Franklin Inst. Press, 137-143, 1981.
22. Harley JP, Ray RS, Tomasi L, et al. Hyperkinesis and food additives: Testing the Feingold hypothesis. Pediatrics 61:818-828, 1978.
23. Harley JP, Matthews CG, and Eichman P. Synthetic food colors and hyperreactivity in children: A double blind challenge experiment. Pediatrics 62:975-980, 1978.
24. National Institutes of Health Consensus Development Panel. Conference statement: Defined diets and hyperactivity. Am J Clin Nutr 37:161-165, 1983.
25. Egger J, Carter CM, Graham PJ, et al. A controlled trial of oligoantigenic diet treatment in the hyper-kinetic syndrome. Lancet 1:940-945, 1985.
26. Carter CM, Urbanowicz M, Hemsley R, et al. Effect of a few-food diet in attention deficit disorder. Arch Dis Child 69:564-568, 1993.
27. Pollock I, and Warner JO. The effect of artificial food colors on childhood behavior. Arch Dis Child 65:74-77, 1990.
28. Bateman B, Hutchinson E, Warner JO, et al. The effects of a double blind placebo controlled artificial food colorings and benzoate preservatives challenge on hyperactivity in a general population sample of pre-school children. Arch Dis Child 89:506-511, 2004.
29. Rowe KS, and Rowe KJ. Synthetic food coloring and behavior: A dose response effect in a double blind placebo controlled repeated-measures study. J Pediatr 125:691-698, 1994.
30. Williams JI, Cram DM, Tausig FT, et al. Relative effects of drugs and diet on hyperactive behaviors: An experimental study. Pediatrics 61:811-817, 1978.
31. Fukuda K, Straus SE, Hickie I, et al. The chronic fatigue syndrome: A comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med 121:953-959, 1994.
32. Rowe PC, Calkins H. Neurally mediated hypotension and chronic fatigue syndrome. Am J Med 105:155-215, 1998.
33. Suhadolnik RJ, Reichembach RW, Sobol RW, et al. Biochemical defects in the 2-5A synthetase/RNase L pathway associated with chronic fatigue syndrome with encephalopathy. In The Clinical and Scientific Basis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Hyde B (Ed). Ottawa, Canada: The Nightingale Research Foundation, 613-617, 1992.
34. Clauw DJ, and Crofford LJ. Chronic widespread pain and fibromyalgia: What we know, and what we need to know. Best Pract Res Clin Rheumatol 17:685-701, 2003.